These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10929446

  • 1. [Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium].
    Ringe JD, Cöster A, Meng T, Schacht E, Umbach R.
    Z Rheumatol; 2000 Jun; 59(3):176-82. PubMed ID: 10929446
    [Abstract] [Full Text] [Related]

  • 2. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW.
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [Abstract] [Full Text] [Related]

  • 3. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD, Faber H, Fahramand P, Schacht E.
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY, Lecart MP, Richy F.
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
    Sambrook PN, Kotowicz M, Nash P, Styles CB, Naganathan V, Henderson-Briffa KN, Eisman JA, Nicholson GC.
    J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alfacalcidol versus plain vitamin D in inflammation induced bone loss.
    Scharla SH, Schacht E, Lempert UG.
    J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848
    [Abstract] [Full Text] [Related]

  • 16. Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.
    Ringe JD, Dorst A, Faber H, Ibach K, Preuss J.
    Rheumatology (Oxford); 2003 Jun; 42(6):743-9. PubMed ID: 12730532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.
    Loddenkemper K, Grauer A, Burmester GR, Buttgereit F.
    Clin Exp Rheumatol; 2003 Jun; 21(1):19-26. PubMed ID: 12673885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.
    Nuti R, Bianchi G, Brandi ML, Caudarella R, D'Erasmo E, Fiore C, Isaia GC, Luisetto G, Muratore M, Oriente P, Ortolani S.
    Rheumatol Int; 2006 Mar; 26(5):445-53. PubMed ID: 16283320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.